3-[(4-Methyl-1,4-diazepan-1-yl)methyl]aniline | 915707-49-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-[(4-Methyl-1,4-diazepan-1-yl)methyl]aniline
• CAS: 915707-49-2
• 化学式: C₁₃H₂₁N₃
• mdl: MFCD09702378
• 分子量: 219.33
• InChiKey: ZSOSQWJKEPUOCI-UHFFFAOYSA-N

物化性质

• 沸点：
  344.9±32.0 °C(Predicted)
• 密度：
  1.060±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  32.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
  申请人：Deciphera Pharmaceuticals, LLC

  公开号：EP3722296A2

  公开（公告）日：2020-10-14

  The invention relates to dihydronaphthyridines and related compounds; compositions comprising an effective amount of a dihydronaphthyridine or a related compound; and methods for treating or preventing proliferative diseases comprising the administration of an effective amount of a dihydronaphthyridine or a related compound. The present invention discloses the unexpected utility of compounds that inhibit c-KIT kinase across a broad range of c-KIT mutations, including complex occurrences of primary mutations (KIT exon 9 or 11) and secondary KIT mutations (exons 13, 14, 17 and 18) that may arise in individual, refractory GIST patients. Also unexpected is the utility of compounds of the present invention to inhibit the problematic exon 17 D816V c-KIT mutation, for which there is currently no effective therapy

  本发明涉及二氢萘啶和相关化合物；包含有效量的二氢萘啶或相关化合物的组合物；以及通过施用有效量的二氢萘啶或相关化合物治疗或预防增殖性疾病的方法。本发明公开了抑制c-KIT激酶的化合物在广泛的c-KIT突变中意想不到的用途，包括可能出现在个别难治性GIST患者中的原发性突变（KIT外显子9或11）和继发性KIT突变（外显子13、14、17和18）的复杂情况。同样出乎意料的是，本发明的化合物还可用于抑制有问题的 17 号外显子 D816V c-KIT 突变，目前尚无有效的治疗方法。